Best in Biotech 19 Aug 2020 7 Biotech Books to Read in the Sun this Summer …of its discoverers In A Crack in Creation, Jennifer Doudna and former colleague Samuel Sternberg share the story behind the discovery of CRISPR, a technology that makes gene editing way… August 19, 2020 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Dec 2019 Update: Cancer Immunotherapy Biotech Files for Insolvency Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in the summer, the German company Mologen has filed for insolvency. Published 06/08/2019 A DNA immunotherapy… December 6, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Dec 2025 Keep an eye on these 15 biotech companies in 2026 …CRISPR systems together with other enzymes to directly install point mutations into cellular DNA or RNA without making double-stranded DNA breaks. In fact, in 2023, the company was the first to… December 15, 2025 - 21 minutesmins - Multiple Authors Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2025 Is an HIV cure possible? The future of HIV therapy …the U.S. within two years. These drugs work by interfering with key steps in HIV’s replication process, for example, blocking the enzyme that converts viral RNA into DNA, or preventing… July 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2022 CRISPR/Cas9: Challenges and outlook from an investor’s perspective …greatest scientific advancements of the last 100 years. In 2012, Jennifer Doudna and Emanuelle Charpentier published a peer-reviewed paper discussing the use of CRISPR/Cas9 in gene editing. They probably didn’t… October 17, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Mar 2024 6 biotech companies tackling antibiotic resistance …focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates that block a new molecular target called DNA polymerase… March 7, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 9 Dec 2020 The Manufacturing Challenge to Meet Covid-19 Vaccine Demands …a pandemic has been challenging to say the least.” Touchlight DNA services, the contract manufacturing arm of UK biotech Touchlight Genetics, aims to support Covid-19 drug and vaccine manufacture by… December 9, 2020 - 5 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 15 Feb 2022 Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials …vaccine development include improving the manufacture, supply, and distribution of Covid-19 vaccines. Additionally, improving vaccine access in these regions could reduce the likelihood of dangerous variants emerging. DNA vaccines are… February 15, 2022 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Mar 2023 7 biotechs in Hungary you should know about …protein CDC7 contributes to DNA replication in cells, however, its overexpression has been regarded as a marker in cancers like colorectal cancer. CDC7 inhibitors target the enzyme CDC7 kinase, which… March 15, 2023 - 9 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 4 Oct 2021 Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain …in development include delivering DNA to tissues via electric currents, as developed by the Parisian firm Eyevensys, and transfection, a technology that relies on small DNA molecules called plasmids to… October 4, 2021 - 5 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
In Depth 4 Nov 2020 The Return of Gene Therapy …DNA sequences into patients’ cells for treating people with genetic disorders. However, they urged caution in the development of the technology, pointing out several key bottlenecks in scientific understanding that… November 4, 2020 - 8 minutesmins - By Farhan Mitha Share WhatsApp Twitter Linkedin Email
News and Trends 24 Feb 2017 What are the Current Challenges in the Booming Field of ADCs? …the minor groove of DNA. The optimally snug fit makes Tesirine the most effective cross-linking agent that is thereby able to damage DNA and induce cell death. On the left,… February 24, 2017 - 5 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email